NCT02912663View on ClinicalTrials.gov

Magnesium And Verapamil After Recanalization in Ischemia of the Cerebrum: a Clinical and Translational Study.

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 11, 2017

Primary Completion Date

January 14, 2020

Study Completion Date

January 14, 2020

Conditions
Ischemic Stroke
Interventions
DRUG

Verapamil and Magnesium Sulfate

Single dose strategy will be used

OTHER

Placebo

Single matching dosing strategy will be used

Trial Locations (1)

40536

University of Kentucky Medical Center, Lexington

All Listed Sponsors
lead

Justin Fraser

OTHER

NCT02912663 - Magnesium And Verapamil After Recanalization in Ischemia of the Cerebrum: a Clinical and Translational Study. | Biotech Hunter | Biotech Hunter